Analysts Expect Aspen Aerogels Inc (ASPN) to Post -$0.13 Earnings Per Share
Wall Street analysts expect Aspen Aerogels Inc (NYSE:ASPN) to report ($0.13) earnings per share (EPS) for the current quarter, according to Zacks. Two analysts have issued estimates for Aspen Aerogels’ earnings. The lowest EPS estimate is ($0.14) and the highest is ($0.11). Aspen Aerogels reported earnings of ($0.25) per share in the same quarter last year, which would suggest a positive year-over-year growth rate of 48%. The business is expected to report its next quarterly earnings results on Thursday, February 22nd.
According to Zacks, analysts expect that Aspen Aerogels will report full-year earnings of ($0.88) per share for the current financial year, with EPS estimates ranging from ($0.89) to ($0.86). For the next fiscal year, analysts expect that the firm will report earnings of ($0.38) per share, with EPS estimates ranging from ($0.41) to ($0.35). Zacks’ earnings per share averages are a mean average based on a survey of analysts that follow Aspen Aerogels.
Aspen Aerogels (NYSE:ASPN) last released its quarterly earnings data on Thursday, November 2nd. The construction company reported ($0.13) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.14) by $0.01. Aspen Aerogels had a negative return on equity of 21.86% and a negative net margin of 22.72%. The firm had revenue of $27.20 million for the quarter, compared to analyst estimates of $28.23 million. During the same quarter in the prior year, the company earned ($0.13) earnings per share. The business’s revenue for the quarter was down 8.1% compared to the same quarter last year.
Aspen Aerogels (ASPN) opened at $5.05 on Monday. Aspen Aerogels has a 12-month low of $3.84 and a 12-month high of $5.20. The company has a market capitalization of $119.37, a P/E ratio of -5.05 and a beta of 1.09.
In other news, major shareholder Craig A. Huff sold 2,895,981 shares of the company’s stock in a transaction that occurred on Thursday, November 30th. The stock was sold at an average price of $4.30, for a total value of $12,452,718.30. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. 16.80% of the stock is currently owned by corporate insiders.
A number of large investors have recently modified their holdings of the stock. Harvey Partners LLC grew its position in Aspen Aerogels by 32.2% during the third quarter. Harvey Partners LLC now owns 379,100 shares of the construction company’s stock worth $1,649,000 after buying an additional 92,432 shares in the last quarter. Royce & Associates LP grew its position in Aspen Aerogels by 12.8% during the third quarter. Royce & Associates LP now owns 660,746 shares of the construction company’s stock worth $2,874,000 after buying an additional 74,792 shares in the last quarter. Dimensional Fund Advisors LP grew its position in Aspen Aerogels by 384.5% during the third quarter. Dimensional Fund Advisors LP now owns 80,149 shares of the construction company’s stock worth $349,000 after buying an additional 63,605 shares in the last quarter. Oaktop Capital Management II L.P. grew its position in Aspen Aerogels by 14.6% during the third quarter. Oaktop Capital Management II L.P. now owns 1,399,001 shares of the construction company’s stock worth $6,086,000 after buying an additional 177,953 shares in the last quarter. Finally, Quantum Capital Management grew its position in Aspen Aerogels by 1,552.9% during the third quarter. Quantum Capital Management now owns 223,966 shares of the construction company’s stock worth $974,000 after buying an additional 210,416 shares in the last quarter. 74.40% of the stock is currently owned by institutional investors and hedge funds.
Aspen Aerogels Company Profile
Aspen Aerogels, Inc is an energy technology company that designs, develops and manufactures aerogel insulation used primarily in energy infrastructure facilities. The Company also performs contract research services for various federal and non-federal government agencies, including the Department of Defense, the Department of Energy and other institutions.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.